E ANDREW SOTOMANGO: Open Payments
NPI 1356976229 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,037 in 323 payments from 21 companies in 2025. Trend: 2023 $5,529 · 2024 $6,707 · 2025 $6,037
Food & beverage: $5,851Education: $185
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $737 |
| Galderma Laboratories, L.P. | 42 | $727 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 29 | $664 |
| Janssen Biotech, Inc. | 28 | $545 |
| Botanix SB Inc | 27 | $505 |
| UCB, Inc. | 26 | $460 |
| GENZYME CORPORATION | 13 | $424 |
| Organon LLC | 25 | $410 |
| Incyte Corporation | 25 | $330 |
| Regeneron Healthcare Solutions, Inc. | 6 | $202 |
Products named: DUPIXENT, NEMLUVIO, TREMFYA, SKYRIZI, SOFDRA, Bimzelx, OPZELURA, Winlevi.
Industry payments across PA — which companies pay providers there.
